Banting Lecture 2001

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

FIG. 10.
FIG. 10.

Hypothetical steps in the etiology of type 2 diabetes. If there is a defect in the leptin signaling system that lowers the sympathetic activity, as seen in animal models, fatty acid oxidation capacity in the muscle will decrease (possibly by altering the ACC/CPT I axis). This will increase the IMCL concentration, which will lower glucose uptake, leading to insulin resistance. To compensate for the decreased insulin sensitivity in muscle, the pancreas increases insulin secretion to maintain NGT. Chronic hyperinsulinemia further diminishes fatty acid oxidation, raising the concentration of fatty acyl-CoA and TG, and interferes with the transport/phosphorylation pathways associated with normal glucose uptake. An elevated concentration of insulin will also increase the output of VLDL by the liver. Circulating VLDL will deposit in the muscle and adipose tissue, which in the early stages of the disease will increase fat deposition. If on top of this hyperphagia is added, the situation deteriorates. Eventually, the ability of the adipose tissue to reesterify FFA is overwhelmed, increasing their concentration in plasma. Excessive FFA will enhance glucose production by the liver, precipitating IGT. In an early stage, the increase of plasma FFA will exacerbate the already existing hyperinsulinemia. Later, they will, through their lipotoxic effect, lead to β-cell failure and overt type 2 diabetes.

This Article

  1. Diabetes vol. 51 no. 1 7-18